Lastly, keep in mind that most studies showing efficacy of GLP-1 agonists for weight loss usually require participants to make lifestyle modifications such as changes in diet and exercise, to control portions and eat high nutrient, low energy foods and move more while taking the medications
The approval stems from the Phase IIIb SOUL trial involving over 9,600 patients, which showed MACE occurred in 12% of Rybelsus-treated patients versus 13.8% on placeboa statistically significant 14% treatment effect
IV treatments are treated differently from oral or topical forms when it comes to safety and evidence
Tirzepatide treatment has been associated with reductions in systolic blood pressure and improvements in lipid parameters
It serves as an important safeguard, protecting patients and helping clinicians make evidence-based decisions
This signals your body to preserve lean mass while you lose fat